Inhibitory effect of a novel non-steroidal aromatase inhibitor, YM511 on the proliferation of MCF-7 human breast cancer cell

Journal of Steroid Biochemistry and Molecular Biology

Volumn 58, Issue 2, 1996, Pages 189-194

  Kudoh, Masafumi ^a   Susaki, Yoko ^a   Ideyama, Yukitaka ^a   Nanya, Taiki ^a   Mori, Masamichi ^a   Shikama, Hisataka ^a   Fujikura, Takashi ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; ESTRADIOL; FADROZOLE; TESTOSTERONE;

ARTICLE; BREAST CANCER; CELL GROWTH; CELL LINE; CONTROLLED STUDY; DNA SYNTHESIS; GENE ACTIVATION; HUMAN; HUMAN CELL; TRANSCRIPTION REGULATION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0030152141     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(96)00023-4     Document Type: Article

References (29)

1. 1. Topper Y.J. and Freeman C.S. (1980) Multiple hormone interactions in the developmental biology of the mammary gland.. Physiol. Rev. 60, 1049-1106.
2. 2. Clarke C.L. and Sutherland R L. (1990) Progestin regulation of cellular proliferation.. Endocr. Rev. 11, 266-301.
3. 3. Osborne C.K., Hamilton B., Titus G. and Livingston R.B. (1980) Epidermal growth factor stimulation on human breast cancer cell in culture.. Cancer Res. 40, 2361-2366.
4. 4. Santen R.J., Manni A., Harvey H.A. and Redmond C. (1990) Endocrine treatment of breast cancer in women.. Endocr. Rev. 11, 221-265.
5. 5. Horwitz K.B. and McGuire W.L. (1980) Nuclear estrogen receptors: effect of inhibitors on processing and steady state levels. J. Biol. Chem. 255, 9699-9705.
6. 6. Eckert R.L., Mullick A., Rorke E.A. and Katzenllenborgen B.S. (1984) Estrogen receptor synthesis and turnover in MCF-7 breast cancer cells measured by a density shift technique. Endocrinology 114, 629-637.
7. 7. Silva M.C., Rowlands M.G., Dowsett M., Gusterson B., McKinna J.A., Fryatt I. and Coombes R.C. (1989) Intratumoral aromatase as a prognostic factor in human breast carcinoma. Cancer Res. 49, 2588-2591.
8. 8. Lipton A., Santner S.J., Santen R.J., Harvey H.A., Feil P.D., White-Hershey D., Bartholomew M.J. and Antle C.E. (1987) Aromatase activity in primary and metastatic human breast cancer. Cancer 59, 779-782.
9. 9. Bulun S.E. and Simpson E.R. (1994) Breast cancer and expression of aromatase in breast adipose tissue. Trends Endocr. Metab. 5, 113-120.
10. 10. Berthois Y., Dong X.F. and Martin P.M. (1989) Regulation of epidermal growth factor-receptor by estrogen and antiestrogen in the human breast cancer cell line MCF-7. Biochem. Biophys. Res. Comm. 159, 126-131.
11. 11. Stewart A.J., Johnson M.D., May F.E.B. and Westley B.R. (1990) Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J. Biol. Chem. 265, 21172-21178.
12. 12. Dowsett M., Macaulay V., Gledhill J., Ryde C., Nicholls J., Ashworth A., McKinna J.A. and Smith I.E. (1993) Control of aromatase in breast cancer cells and its importance for tumor growth. J. Steroid Biochem. Mol. Biol. 44, 605-609.
13. 13. Santner S.J., Chen S., Zhou D., Korsunsky D., Martel J. and Santen R.J. (1993) Effect of androstenedione on growth of untransfected and aromatase-transfected MCF-7 cells in culture. J. Steroid Biochem. Mol. Biol. 44, 611-616.
14. 14. Kitawaki J., Fukuoka M., Yamamoto T., Honjo H. and Okada H. (1992) Contribution of aromatase to the deoxyribonucleic acid synthesis of MCF-7 human breast cancer cells and its suppression by aromatase inhibitors. J. Steroid Biochem. Mol. Biol. 42, 267-277.
15. 15. Kitawaki J., Kim T., Kanno H., Noguchi T., Yamamoto T. and Okada H. (1993) Growth suppression of MCF-7 human breast cancer cells by aromatase inhibitors: a new system for aromatase inhibitor screening. J. Steroid Biochem. Mol. Biol. 44, 667-670.
16. 16. Kudoh M., Susaki Y., Ideyama Y., Nanya T., Okada M., Shikama H. and Fujikura T. (1995) The potent and selective inhibition of estrogen production by non-steroidal aromatase inhibitor YM511. J. Steroid Biochem. Mol. Biol. 54, 265-271.
17. 17. Steele R.E., Mellor L.B., Sawyer W.K., Wasvary J.M. and Browne L.L. (1987) In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949A. Steroids 50, 147-161.
18. 18. Lipton A., Harvey H.A., Demers L.M., Hanagan J.R., Mulagha M.T., Kochak G.M., Fitzsimmons S., Sanders S.I. and Santen R.J. (1990) A phase 1 trial of CGS 16949A. Cancer 65, 1279-1285.
19. 19. Gratzner H.G. (1982) Monoclonal antibody to 5-bromo-and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 218, 474-475.
20. 20. Klein-Hitpass L., Ryffel G.U., Heitlinger E. and Cato A.C.B. (1988) A 13 bp palindrome is a function estrogen responsive element and interacts specifically with estrogen receptor. Nucl. Acids Res. 16, 647-663.
21. 21. Sambrook J., Fritsch E. F. and Maniatis T.: Molecular Cloning. 2nd edn., Cold Spring Harbor Press, New York (1989), p. 16-32.
22. 22. de Wet J.R., Wood K.V., DeLuca M., Helinski D.R. and Subramani S. (1987) Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7, 725-737.
23. 23. Zuber P. and Losick R. (1983) Use of a lacZ fusion to study the role of the spoO genes of Bacillus subtilis in developmental regulation. Cell 35, 275-283.
24. 24. Santen R.J., Santner S., Davis B., Veldhuis J., Samojlik E. and Ruby E. (1978) Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma. J. Clin. Endocr. Metab. 47, 1257-1265.
25. 25. Wiseman L.R. and McTavish D. (1993) Fortmestane: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of breast cancer and prostatic cancer. Drugs 45, 66-84.
26. 26. MacIndoe J.H. (1979) Estradiol formation from testosterone by continuously cultured human breast cancer cells. J. Clin. Endocr. Metab. 49, 272-277.
27. 27. Macaulay V.M., Nicholls J.E., Gledhill J., Rowlands M.G., Dowsett M. and Ashworth A. (1994) Biological effects of stable overexpression of aromatase in human hormone-dependent breast cancer cells. Br. J. Cancer 69, 77-83.
28. 28. Bulun S.E., Price T.M., Aitken J., Mahendroo M.S. and Simpson E.R. (1993) A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J. Clin. Endocr. Metab. 77, 1622-1628.
29. 29. Chetkowski R.J., Meldrum D.R., Steingold K.A., Randle D., Lu J.K., Eggena P., Hershman J.M., Alkjaersig N.K., Fletcher A.P. and Judd H.L. (1986) Biological effects of transdermal estradiol. N. Engl J. Med. 314, 1615-1620.